PDS Biotechnology Highlights PDS-0301 Slideshow Data
PDS Biotechnology Corporation published a corporate slideshow detailing the PDS-0301 immunocytokine and its role in treating metastatic colorectal cancer. Investors tracking clinical pipeline updates on Saturday, October 17, 2026, are reviewing the newly released presentation materials filed with the market.
If $PDSB+WL clinical milestones advance further, watch shares for potential multiple expansion or increased institutional sponsorship in the biotech sector.